Abbott Laboratories ABT
NYSE ABT
$97.50 +0.80 (+0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026)

Updated

Abbott Laboratories' Cash & Equivalents was $5.1 billion in Q2 2026, down 26.6% from $6.95 billion a year earlier and down 25.0% from the prior quarter.

Analysis

Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Abbott Laboratories came in at $8.52 billion, up 11.9% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $7.62 billion in FY2024 (+10.4%), $6.9 billion in FY2023 (-30.2%), $9.88 billion in FY2022 (+0.8%) and $9.8 billion in FY2021 (+43.3%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q3 2020.
  • Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 1.9%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 107.6%); the worst was Q1 2024 (a decline of 31.4%).
  • Per Business Quant data, ABT's Cash & Equivalents in the three quarters before Q2 2026 was $6.8 billion (Q1 2026), $8.52 billion (Q4 2025) and $7.51 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 5.10 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 2.76 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 1.69 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 3.39 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 2.91 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 708.00 Mn
10 Agilent Technologies 46.99 Bn 39.88 Bn 1.04 Bn 1.76 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.10 Bn
Mar 31, 2026 6.80 Bn
Dec 31, 2025 8.52 Bn
Sep 30, 2025 7.51 Bn
Jun 30, 2025 6.95 Bn
Mar 31, 2025 6.53 Bn
Dec 31, 2024 7.62 Bn
Sep 30, 2024 7.56 Bn
Jun 30, 2024 6.99 Bn
Mar 31, 2024 6.28 Bn
Dec 31, 2023 6.90 Bn
Sep 30, 2023 6.71 Bn
Jun 30, 2023 7.84 Bn
Mar 31, 2023 9.16 Bn
Dec 31, 2022 9.88 Bn
Sep 30, 2022 9.59 Bn
Jun 30, 2022 8.94 Bn
Mar 31, 2022 7.68 Bn
Dec 31, 2021 9.80 Bn
Sep 30, 2021 9.30 Bn
API Access

Abbott Laboratories Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABT&period=max&api_key=YOUR_API_KEY